This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Great Donut Debate Hits Delicious Dilemma

The company plans to host an earnings conference call to review the results of its fiscal 2014 first quarter results and present management's outlook for the balance of fiscal 2014 at 4:30 p.m. (ET) on Thursday. There'll be a live webcast of the conference call available at its home webpage.

Analysts will be listening carefully and expect this quarter's EPS to have increased by an average estimate of over 21% from the same year-ago quarter.

When it comes to sales growth and revenue, the same group of analysts is looking for around a 7% year-over-year quarterly improvement. KKD had huge positive earnings surprises virtually every quarter in the previous fiscal year. Yet in the last quarter it disappointed by 25% which barely moved the stock's price.

Here's a one-year chart including the recent history of revenue per share (TTM) and EBIDTA earnings. You can see that KKD took off in late 2012 and never looked back including Tuesday's 3.2% rally.

KKD Chart KKD data by YCharts

KKD isn't the only donut shop in town. The Great Donut Debate swirls around the question, "Which has the best, freshest, most mouth-watering donuts and coffee?" More people are saying it's Dunkin' Brands (DNKN - Get Report).

From my own random sampling of Americans DNKN was referred to as "the healthier donut" and KKD was called "the most consistently tantalizing and best-smelling donut."

DNKN donuts claimed a few years ago that its donuts don't have trans-fats or other artery-clogging ingredients. I don't know if that's still true but it sounded positive. When it comes to sugar content I imagine both companies' donuts have all that our pancreas can handle.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DNKN $54.03 0.00%
KKD $19.34 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs